A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Completed · Phase 3

Conditions studied: Glaucoma, Open-Angle, Ocular Hypertension

In brief

To demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure measurements at 8 AM, 10 AM, 4 PM at weeks 2, 6 and 12.

Key facts

Study ID

NCT00159653

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

500

Starts

2005-07-01

Expected to finish

2007-06-01

Last updated by the study team

2021-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Uni- or bilateral diagnosis of primary open angle glaucoma or ocular hypertension on beta-blocker monotherapy or dual therapy in which at least one medication is a beta-blocker for at least 4 weeks prior to screening

You may not qualify if…

• Closed/ barely open anterior chamber angle or history of acute angle closure glaucoma.
• History of ALT (Argon Laser Trabeculoplasty) or SLT(selective Laser) within 3 months prior to screening

Where it is running

• Pfizer Investigational Site — Poway, California, United States
• Pfizer Investigational Site — Redding, California, United States
• Pfizer Investigational Site — Redding, California, United States
• Pfizer Investigational Site — Danbury, Connecticut, United States
• Pfizer Investigational Site — Cape Coral, Florida, United States
• Pfizer Investigational Site — Lakeland, Florida, United States
• Pfizer Investigational Site — Ormond Beach, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Morrow, Georgia, United States
• Pfizer Investigational Site — Homewood, Illinois, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — North Dartmouth, Massachusetts, United States
• Pfizer Investigational Site — Saint Joseph, Michigan, United States
• Pfizer Investigational Site — Lincoln, Nebraska, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States
• Pfizer Investigational Site — Newark, New Jersey, United States
• Pfizer Investigational Site — Bethpage, New York, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.